Abstract
Background: This meta-analysis aims to evaluate the long-term efficacy of medication treatment vs. surgery treatment in patients with prolactinomas.Methods: An electronic literature search was performed using MEDLINE, EMBASE and Web of Science databases for studies dated before July in 2018. Patients with prolactinomas received primary dopamine agonists (DAs) treatment or primary surgical interventions were included in this study. A systematic review and meta-analysis were performed in pertinent studies meeting eligible criteria. The clinical outcome was measured by the long-term remission rate of prolactin (PRL) in each cohort. The pooled data was analyzed according to a random effect model.Results: Thirteen publications with total 809 patients were included in the final meta-analysis. In the overall patients with prolactinomas, long-term remission rate was achieved in 88% patients treated with surgeries and in 52% patients treated with DAs (P = 0.001). The long-term remission rates in surgery cohort were also significantly higher than medication cohort in both microprolactinomas and macroprolactinomas (91 vs. 60%, P = 0.002; 77 vs. 43%, P = 0.003).Conclusions: Patients with prolactinomas, especially microprolactinomas, can consider transsphenoidal surgery as an alternative first-line treatment strategy. After receiving primary surgical intervention, administration of DAs should be considered based on the postoperative PRL level to achieve the best long-term remission rate.
Highlights
Prolactinomas, one of the pituitary adenoma that synthesize prolactin (PRL), account for up to 45% of all pituitary adenomas and are highly associated with symptoms according to hyperprolactinemia in clinical practice [1]
Microprolactinomas exhibit relatively low secretion of PRL and better prognosis while macroprolactinomas are more often associated with particular difficulties in management due to their high secretion of PRL and aggressive biological behaviors [3, 4]
Based on the fact that modern neurosurgical techniques for pituitary approaches have been remarkably developed over the last decades, especially the development of endoscopic transsphenoidal surgery, normalized PRL level and restored gonadal function following complete resection of tumor have been shown in emerging cases with infrequent severe complications [16,17,18]
Summary
Prolactinomas, one of the pituitary adenoma that synthesize prolactin (PRL), account for up to 45% of all pituitary adenomas and are highly associated with symptoms according to hyperprolactinemia in clinical practice [1]. Based on the fact that modern neurosurgical techniques for pituitary approaches have been remarkably developed over the last decades, especially the development of endoscopic transsphenoidal surgery, normalized PRL level and restored gonadal function following complete resection of tumor have been shown in emerging cases with infrequent severe complications [16,17,18]. This meta-analysis aims to evaluate the long-term efficacy of medication treatment vs surgery treatment in patients with prolactinomas
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
